Appili Manufacturing Partner Wins FDA Approval

The U.S. manufacturing partner of Halifax drug discovery company Appili Therapeutics has won Food and Drug Administration approval to sell Appili’s liquid formulation of the common antibiotic metronidazole under the name LIKMEZ.
The news comes just four months after Appili announced it had secured a U.S. patent for the new formulation, which will be manufactured and sold south of the border by